BioRestorative Therapies (BRTX) Institutional Ownership $1.56 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for BioRestorative Therapies (NASDAQ:BRTX)CurrentInstitutional OwnershipPercentage69.38%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$48.09KNumber ofInstitutional Sellers(last 12 months)0 Get BRTX Insider Trade Alerts Want to know when executives and insiders are buying or selling BioRestorative Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Chaikin AnalyticsSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). BioRestorative Therapies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/1/2024StoneX Group Inc.34,850$48K0.0%N/A0.515% 11/1/2023Lynwood Capital Management Inc.20,000$36K0.1%N/A0.428% 10/10/2023FNY Investment Advisers LLC14,665$26K0.0%N/A0.314% (Data available from 1/1/2016 forward) BRTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BRTX shares? During the previous two years, the following institutional investors and hedge funds held shares of BioRestorative Therapies shares: StoneX Group Inc. ($48K), and Lynwood Capital Management Inc. ($36K), FNY Investment Advisers LLC ($26K).Learn more on BRTX's institutional investors. What percentage of BioRestorative Therapies stock is owned by institutional investors? 69.38% of BioRestorative Therapies stock is owned by institutional investors. Learn more on BRTX's institutional investor holdings. Which institutional investors have been buying BioRestorative Therapies stock? The following institutional investors have purchased BioRestorative Therapies stock in the last 24 months: StoneX Group Inc. ($34.85K), Lynwood Capital Management Inc. ($20K), and FNY Investment Advisers LLC ($14.67K). How much institutional buying is happening at BioRestorative Therapies? Institutional investors have bought a total of 69,515 shares in the last 24 months. This purchase volume represents approximately $110.14K in transactions. Related Companies Concord Medical Services Institutional Ownership Burning Rock Biotech Institutional Ownership Oncology Institute Institutional Ownership Renalytix Institutional Ownership Psychemedics Institutional Ownership Marpai Institutional Ownership CareMax Institutional Ownership Ontrak Institutional Ownership BioNexus Gene Lab Institutional Ownership Kindly MD Institutional Ownership This page (NASDAQ:BRTX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
